Effects of Colchicine on Atherosclerotic Plaque Stabilization: a Multimodality Imaging Study in an Animal Model

Alberto Cecconi1,2, Jean Paul Vilchez-Tschischke1,3, Jesus Mateo1

  • 1Centro Nacional de Investigaciones Cardiovasculares (CNIC), Calle de Melchor Fernández Almagro, 3, 28029, Madrid, Spain.

Insights

Colchicine may stabilize atherosclerotic plaques by reducing inflammation and plaque burden. This study in rabbits suggests colchicine

Area of Science:

  • Cardiovascular Research
  • Inflammation Biology
  • Medical Imaging

Background:

  • Stable coronary artery disease (CAD) benefits from colchicine.
  • Atherosclerotic plaque stabilization is a key therapeutic goal in CAD.

Purpose of the Study:

  • To evaluate colchicine's effects on atherosclerotic plaque stabilization.
  • To assess colchicine's impact on plaque inflammation and burden.

Main Methods:

  • Atherosclerosis induced in rabbit abdominal aorta via high-cholesterol diet and balloon injury.
  • Animals randomized to colchicine or placebo treatment.
  • Multimodal imaging including MRI, 18F-FDG PET/CT, OCT, and histology used for assessment.

Main Results:

  • No significant difference in atherosclerotic burden (normalized wall index) between groups.
  • Colchicine treatment led to a decrease in maximum 18F-FDG standardized uptake value (meanSUVmax), indicating reduced inflammatory activity, while placebo showed an increase.
  • Animals with higher cholesterol levels showed significant benefits with colchicine regarding plaque burden and reduced inflammatory activity.

Conclusions:

  • Colchicine may stabilize atherosclerotic plaques by reducing inflammatory activity.
  • The drug appears to reduce plaque burden without altering macrophage infiltration or plaque typology.
  • Findings support colchicine's potential role in managing atherosclerosis.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
272
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
186
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
684